Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Ousterout

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|October 8, 2015
The Development of TALE Nucleases for BiotechnologyDavid G Ousterout, Charles A Gersbach
Journal of Virology|May 21, 2010
Feline lectin activity is critical for the cellular entry of feline infectious peritonitis virusAndrew D Regan, David G Ousterout, Gary R Whittaker
Current Opinion in Chemical Biology|July 24, 2012
Advances in targeted genome editingPablo Perez-Pinera, David G Ousterout, Charles A Gersbach
Nucleic Acids Research|December 16, 2011
Gene targeting to the ROSA26 locus directed by engineered zinc finger nucleasesPablo Perez-Pinera, David G Ousterout, Matthew T Brown, et al.
Nucleic Acids Research|August 15, 2014
Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vectorAmi M Kabadi, David G Ousterout, Isaac B Hilton, et al.
Nature Communications|February 19, 2015
Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophyDavid G Ousterout, Ami M Kabadi, Pratiksha I Thakore, et al.
ACS Synthetic Biology|December 11, 2014
Enhanced MyoD-induced transdifferentiation to a myogenic lineage by fusion to a potent transactivation domainAmi M Kabadi, Pratiksha I Thakore, Christopher M Vockley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2014
Correction of dystrophin expression in cells from Duchenne muscular dystrophy patients through genomic excision of exon 51 by zinc finger nucleasesDavid G Ousterout, Ami M Kabadi, Pratiksha I Thakore, et al.
Nature Methods|February 5, 2013
Synergistic and tunable human gene activation by combinations of synthetic transcription factorsPablo Perez-Pinera, David G Ousterout, Jonathan M Brunger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2013
Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patientsDavid G Ousterout, Pablo Perez-Pinera, Pratiksha I Thakore, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|October 8, 2015
The Development of TALE Nucleases for BiotechnologyDavid G Ousterout, Charles A Gersbach
Journal of Virology|May 21, 2010
Feline lectin activity is critical for the cellular entry of feline infectious peritonitis virusAndrew D Regan, David G Ousterout, Gary R Whittaker
Current Opinion in Chemical Biology|July 24, 2012
Advances in targeted genome editingPablo Perez-Pinera, David G Ousterout, Charles A Gersbach
Nucleic Acids Research|December 16, 2011
Gene targeting to the ROSA26 locus directed by engineered zinc finger nucleasesPablo Perez-Pinera, David G Ousterout, Matthew T Brown, et al.
Nucleic Acids Research|August 15, 2014
Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vectorAmi M Kabadi, David G Ousterout, Isaac B Hilton, et al.
Nature Communications|February 19, 2015
Multiplex CRISPR/Cas9-based genome editing for correction of dystrophin mutations that cause Duchenne muscular dystrophyDavid G Ousterout, Ami M Kabadi, Pratiksha I Thakore, et al.
ACS Synthetic Biology|December 11, 2014
Enhanced MyoD-induced transdifferentiation to a myogenic lineage by fusion to a potent transactivation domainAmi M Kabadi, Pratiksha I Thakore, Christopher M Vockley, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2014
Correction of dystrophin expression in cells from Duchenne muscular dystrophy patients through genomic excision of exon 51 by zinc finger nucleasesDavid G Ousterout, Ami M Kabadi, Pratiksha I Thakore, et al.
Nature Methods|February 5, 2013
Synergistic and tunable human gene activation by combinations of synthetic transcription factorsPablo Perez-Pinera, David G Ousterout, Jonathan M Brunger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2013
Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patientsDavid G Ousterout, Pablo Perez-Pinera, Pratiksha I Thakore, et al.
Pageof 2